November 2025
The global pancreatic cancer precision medicine market size is estimated to hit around USD 4,030.16 million 2034 increasing from USD 823.30 million in 2025, with a CAGR of 19.30%.
July 2025
The global next-generation cancer therapeutics market size was evaluated at USD 86.20 billion in 2024 and is predicted to hit around USD 175.20 billion by 2034, growing at a CAGR of 7.35%.
May 2026
The pancreatic cancer market size was estimated at USD 3.25 billion in 2025 and it is expected to be hit around USD 11.47 billion by 2035 at a CAGR of 13.44%.
March 2026
The global precision medicine market size is expected to increase from USD 119.03 billion in 2025 and is expected to hit around USD 537.17 billion by 2035, with a CAGR of 16.26%.
February 2026
The artificial intelligence (AI) in precision medicine market size is projected to hit around USD 60.24 billion by 2035 from USD 3.15 billion in 2025 with a CAGR of 34.33%.
December 2025
The global non-oncology precision medicine market size is calculated at USD 92.21 billion in 2025 and is projected to hit around USD 222.95 billion by 2035 with a CAGR of 9.23%.
June 2025
The U.S. precision medicine market size surpassed USD 49.79 billion in 2024 and is predicted to reach around USD 232.49 billion by 2034 with a solid CAGR of 16.66%.
August 2025
The global immuno-oncology antibodies market is growing. Learn about market drivers, therapeutic applications, and the companies driving innovation.
August 2025
The global generative AI in personalized medicine market size reached USD 1.84 billion in 2024 and is projected to hit around USD 57.33 billion by 2034 with a CAGR of 38.24%
June 2025
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
September 2025
The global metabolomics market size was evaluated at USD 3.77 billion in 2024 and is predicted to hit around USD 14.40 billion by 2034, growing at a CAGR of 14.34%.
August 2025
The next-generation RNA therapeutics market is growing with innovations in RNA-based drugs, improving treatments for cancer, genetic diseases, and infectious conditions.
August 2025
The global pulmonary alveolar proteinosis (PAP) drugs market size was evaluated at USD 750.05 million in 2024 and is predicted to hit around USD 1,478.22 million by 2034, growing at a CAGR of 7.02%.
July 2025
The global cell analysis market size is estimated to hit around USD 84.01 billion by 2034 increasing from USD 32.95 billion in 2024, with a CAGR of 9.81%.
July 2025
The global artificial intelligence in bioinformatics market size was evaluated at USD 8.80 billion in 2024 and is predicted to hit around USD 33.52 billion by 2034, at a CAGR of 14.31%.
July 2025
The global next-generation biologics market size was evaluated at USD 110.58 billion in 2024 and is predicted to hit around USD 301.22 billion by 2034, growing at a CAGR of 10.54% from 2025 to 2034.
July 2025
The global custom antibody market size was calculated at USD 192.80 million in 2024 and is expected to attain around USD 481.76 million by 2034 with a CAGR of 9.59%.
July 2025
Explore the pan-tumor oncology treatment market, driven by breakthroughs in immunotherapy, targeted treatments, and the rise of tumor-agnostic drug approvals across multiple cancer types.
July 2025
The global FFPE tissue samples for genomics study and analysis market size is estimated to hit around USD 1,548.29 million by 2034 from USD 937.04 million in 2024, with a CAGR of 5.15%.
June 2025
The global genetic analysis market size was valued at USD 7.88 billion in 2024 and is expected to attain around USD 21.67 billion by 2034 with a CAGR of 11.08%.
June 2026
The U.S. concierge medicine market size is valued at USD 6.55 billion in 2025 and is projected to be worth around USD 12.75 billion by 2035 with CAGR of 6.88%.
June 2026
The solid tumor cancer treatment market size was valued at USD 5.64 billion in 2025 and is projected to hit around USD 9.14 billion by 2035 with a CAGR of 4.95%.
June 2026
The global oral cancer rapid test kit market size is estimated to hit around USD 3.94 billion by 2035 increasing from USD 2.38 billion in 2025, with a CAGR of 5.17%.
June 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
June 2026
The global personalized medicine market was estimated at USD 654.46 billion in 2025 and is expected to hit around USD 1397.63 billion by 2035, at a CAGR of 7.88%%.
June 2026
The global precision gearbox market size is calculated at USD 5.02 billion in 2025 and is projected to hit around USD 11.65 billion by 2035 with a CAGR of 8.78%.
June 2026
The US personalized medicine market size was evaluated at USD 192.21 billion in 2025 and is predicted to hit around USD 427.17 billion by 2035, growing at a CAGR of 8.31%.
June 2026
The colorectal cancer diagnostics market size reached USD 16.9 billion in 2025 and is estimated to hit around USD 38.66 billion by 2035 with a CAGR of 8.63%.
June 2026
The global U.S. regenerative medicine market size was evaluated at USD 19.77 billion in 2025 and is predicted to hit around USD 102.23 billion by 2035, growing at a CAGR of 17.86%.
June 2026
The global breast cancer therapeutics market size was valued at USD 33.45 billion in 2025 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com